"Amiodarone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
Below are MeSH descriptors whose meaning is more general than "Amiodarone".
Below are MeSH descriptors whose meaning is more specific than "Amiodarone".
This graph shows the total number of publications written about "Amiodarone" by people in this website by year, and whether "Amiodarone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Amiodarone" by people in Profiles.
Amiodarone and thyroid physiology, pathophysiology, diagnosis and management. Trends Cardiovasc Med. 2019 07; 29(5):285-295.
Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group. Heart Rhythm. 2017 07; 14(7):991-997.
To use or not to use? Amiodarone before heart transplantation. Surgery. 2017 05; 161(5):1273-1278.
Effect of simvastatin-amiodarone drug interaction alert on appropriate prescribing. Am J Health Syst Pharm. 2013 Nov 01; 70(21):1878-9.
Administration of amiodarone during resuscitation is associated with higher tumor necrosis factor-a levels in the early postarrest period in the swine model of ischemic ventricular fibrillation. J Interferon Cytokine Res. 2013 Jun; 33(6):292-6.
Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial. Eur Heart J. 2012 Dec; 33(24):3105-13.
A myriad of pathways to NASH. Clin Liver Dis. 2012 Aug; 16(3):525-48.
Incessant monomorphic ventricular tachycardia induced by the proarrhythmic effect of amiodarone. Intern Med. 2011; 50(21):2591-5.
Inhibition of the type 2 iodothyronine deiodinase underlies the elevated plasma TSH associated with amiodarone treatment. Endocrinology. 2010 Dec; 151(12):5961-70.
Combination prophylactic therapy for post-operative atrial fibrillation. J Am Coll Cardiol. 2008 Jul 29; 52(5):397; author reply 397-8.